臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tien f m"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1-25 / 115 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-08-23T02:35:03Z	Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-05-02T07:33:36Z	Feasibility, process, and effects of short-term calorie reduction in cancer patients receiving chemotherapy: An integrative review	Tang C.-C.; Chen H.; Huang T.-C.; WEI-WEN WU; Lin J.-M.; Tien F.-M.
臺大學術典藏	2022-05-02T02:02:03Z	Safety, feasibility, and effects of short-term calorie reduction during induction chemotherapy in patients with diffuse large b-cell lymphoma: A pilot study	CHIA-CHUN TANG; Huang T.-C.; Tien F.-M.; Lin J.-M.; Yeh Y.-C.; Lee C.-Y.
臺大學術典藏	2022-04-25T07:36:14Z	Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA	Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; JIA-HAU LIU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏	2022-04-25T07:36:12Z	Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission	Tien F.-M.; Tsai C.-H.; Huang S.-C.; JIA-HAU LIU; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F.
臺大學術典藏	2022-04-25T07:36:12Z	Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan	Tien F.-M.; Tsai C.-H.; JIA-HAU LIU; Lin C.-T.
臺大學術典藏	2022-04-25T07:36:11Z	Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study	Wang Y.-H.; Tien F.-M.; Tsai C.-H.; Huang H.-H.; JIA-HAU LIU; Liao X.-W.; Tang J.-L.; Yao M.; Ko B.-S.
臺大學術典藏	2022-04-25T07:36:11Z	Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-04-25T03:57:25Z	Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML	Tsai C.-H;Tang J.-L;Tien F.-M;Kuo Y.-Y;Wu D.-C;Lin C.-C;Tseng M.-H;Peng Y.-L;Hou M.-F;Chuang Y.-K;Liu M.-C;Liu C.-W;Yao M;Lin L.-I;Chou W.-C;Chen C.-Y;Hou H.-A;Tien H.-F.; Tsai C.-H; Tang J.-L; Tien F.-M; Kuo Y.-Y; Wu D.-C; Lin C.-C; Tseng M.-H; Peng Y.-L; Hou M.-F; Chuang Y.-K; Liu M.-C; Liu C.-W; Yao M; Lin L.-I; Chou W.-C; Chen C.-Y; Hou H.-A; Tien H.-F.; CHIEN-YU CHEN
臺大學術典藏	2022-02-07T07:49:00Z	Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-01-12T07:07:19Z	Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients	Tien F.-M.; HSIN-AN HOU; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:18Z	GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia	Tien F.-M.; HSIN-AN HOU; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:17Z	Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA	Tien F.-M.; HSIN-AN HOU; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:15Z	Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients	Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:12Z	Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax	Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:11Z	ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden	Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; HSIN-AN HOU; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:10Z	Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission	Tien F.-M.; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; HSIN-AN HOU; Tang J.-L.; Tien H.-F.
臺大學術典藏	2022-01-12T07:07:09Z	Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience	Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏	2022-01-12T07:07:07Z	Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML	Tsai C.-H.; Tang J.-L.; Tien F.-M.; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F.
臺大學術典藏	2021-08-16T08:36:18Z	Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan	Chen C.-Y.; Tien F.-M.; ARISTINE CHENG; Huang S.-Y.; Chou W.-C.; Yao M.; Tang J.-L.; Tien H.-F.; Sheng W.-H.
臺大學術典藏	2021-08-16T08:36:15Z	Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies	Chen C.-Y.; ARISTINE CHENG; Tien F.-M.; Lee P.-C.; Tien H.-F.; Sheng W.-H.; Chen Y.-C.
臺大學術典藏	2021-07-22T03:35:55Z	Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA	Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; LIU JIA-HAU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F.
臺大學術典藏	2021-07-22T03:35:54Z	Brentuximab vedotin as a salvage treatment for relapsed and refractory Hodgkin lymphoma patients in Taiwan	Tien F.-M.; Tsai C.-H.; LIU JIA-HAU; Lin C.-T.
臺大學術典藏	2021-07-22T03:35:53Z	Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study	Wang Y.-H.; Tien F.-M.; Tsai C.-H.; Huang H.-H.; LIU JIA-HAU; Liao X.-W.; Tang J.-L.; Yao M.; Ko B.-S.
臺大學術典藏	2021-07-21T03:42:30Z	Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax	Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; LIN YUN-CHU; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F.

顯示項目 1-25 / 115 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2853327
	造訪人次 : 44988992 線上人數 : 1986 教育部委託研究計畫計畫執行:國立臺灣大學圖書館